Successful Renal Transplantation in a Patient with Congenital Generalized Lipodystrophy: A Case Report

American Journal of Transplantation

Volumn 4, Issue 3, 2004, Pages 447-449

  McNally, Michael ^a   Mannon, Roslyn B ^b   Javor, Edward D ^b   Swanson, S John ^b   Hale, Douglas A ^b   Gorden, Phillip ^b   Kirk, Allan D ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEGA 3 FATTY ACID; RECOMBINANT LEPTIN; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DIABETES MELLITUS; EDEMA; FEMALE; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIPODYSTROPHY; LIVING DONOR; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

FEMALE; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; LIPID METABOLISM; LIPODYSTROPHY; MIDDLE AGED;

EID: 1442338500     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00358.x     Document Type: Article

References (21)

1. Schonenberg TH. Lipodystrophy in infant and child. Ann Paediatr 1956; 187: 425-436.
2. Weir-Mitchell S. Singular case of absence of adipose matter in upper half of the body. Am J Med Sci 1885; 90: 105-106.
3. Lawrence RD. Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances. Lancet 1946; 1: 773-775.
4. Senior B, Gellis SS. The syndromes of total lipodystrophy and partial lipodystrophy. Pediatrics 1964; 33: 593-612.
5. Magre J, Delepine M, Khallouf E et al. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 2001; 28: 365.
6. Van Maldergem L, Magre J, Khallouf T et al. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet 2002; 39: 722-733.
7. Saito I, Saruta T, Iyori S, Sakaguchi H. The renal lesion associated with total lipodystrophy. J Am Geriatr Soc 1977; 25: 175-178.
8. Casali RE, Resnick J, Goetz F, Simmons RL, Najarian JS, Kjell-strand C. Renal transplantation in a patient with lipoatrophic diabetes. A case report. Transplantation 1978; 26: 174-177.
9. Ishii J, Abe M, Kubo M et al. Total lipodystrophy with heart failure and renal failure: report of a case. Jpn J Med 1989; 28: 534-537.
10. Mathieson PW, Wurzner R, Oliveria DB et al. Complement-mediated adipocyte lysis by nephritic factor sera. J Exp Med 1993; 177: 1827-1831.
11. Hunter AM, Lawson AA, Thompson D. Partial lipodystrophy with nephritic syndrome. Postgrad Med J 1978; 54: 286-291.
12. Wayte J, Bird G, Wikinson JD. The clinical significance of partial lipoatrophy and C3 hypocomplementaemia: a report of 2 cases. Clin Exp Dermatol 1996; 21: 131-134.
13. Meyrier A. The patient with glomerulonephritis and lipodystrophy. Nephrol Dial Transplant 1997; 12: 226-227.
14. Schmidt P, Kerjaschki D, Syre G et al. Recurrence of intramembraneous glomerulonephritis in 2 consecutive kidney transplantations. J Sussie de Medecine 1978; 108: 781-788.
15. Chopra S, Isaacs R, Mammen K, Pawar B. Renal transplantation in a patient with Barraquer-Simons disease and mesangiocapillary glomerulonephritis type II. Nephrol Dial Transplant 2000; 15: 1723-1724.
16. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 1: 425-432.
17. Stephens TW, Baslnski M, Bristow PK et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-532.
18. Hwa JJ, Fawzi AB, Grazian MP et al. Leptin increases energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol 1997; 272: R1204-R1209.
19. Stein DT, Dobbins R, Szczepaniak L, Malloy C, McGarry JD. Skeletal muscle triglyceride stores are increased in insulin resistance. Diabetes 1997; 46: 23A.
20. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438.
21. Oral EA, Simha V, Ruiz E et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002; 21: 570-578.